Recall
FDAHealthNovember 6, 2025

Fresenius Kabi USA, LLC — Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

⚠️ Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 6, 2025

Nationwide within the United States as well as AK, HI, and PR.

What's affected?

Product
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
UPC
0363323739119
Lot code
6133156

Additional details

Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 2,199,850 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.